Zachary Heidrick
Overview
Explore the profile of Zachary Heidrick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tashi M, Shafiee B, Sakamaki Y, Hu J, Heidrick Z, Khosropour A, et al.
RSC Adv
. 2022 May;
8(66):37835-37840.
PMID: 35558628
The combination of continuous flow technology with immobilizing of only 0.13 mol% of triflic acid (TfOH) on silica-encapsulated superparamagnetic iron oxide nanoparticles (SPIONs) under solvent-free conditions successfully provided a powerful,...
2.
Burgin S, Sakamaki Y, Tsuji M, Watson O, Heidrick Z, Chitwood T, et al.
J Chem Educ
. 2021 Aug;
97(8):2351-2355.
PMID: 34354299
Described is the creation, deployment, and evaluation of a video produced about the synthesis and applications of metal-organic frameworks (MOFs). The goal of this project was to gauge the impact...
3.
Sakamaki Y, Ozdemir J, Heidrick Z, Azzun A, Watson O, Tsuji M, et al.
ACS Appl Bio Mater
. 2021 Aug;
4(2):1432-1440.
PMID: 34337346
The field of photodynamic therapy (PDT) has continued to show promise as a potential method for treating tumors. In this work a photosensitizer (PS) has been delivered to cancer cell...
4.
Sakamaki Y, Tsuji M, Heidrick Z, Watson O, Durchman J, Salmon C, et al.
J Chem Educ
. 2021 Jun;
97(4):1109-1116.
PMID: 34113047
The chemistry of metal-organic frameworks (MOFs), a new class of emerging crystalline porous solids with three-dimensional (3D) networks composed of metals and multidentate organic molecules, was introduced by using three...
5.
Sakamaki Y, Ozdemir J, Diaz Perez A, Heidrick Z, Watson O, Tsuji M, et al.
Adv Ther (Weinh)
. 2020 Oct;
3(8).
PMID: 33072859
Herein, we report a nano-MOF conjugated to maltotriose as a new DDS. MA-PCN-224-0.1Mn/0.9Zn showed its ability to target cancer and TAM. This novel MOF is an effective PDT agent and...